Restricted accessResearch articleFirst published online 2022-07
A Heavy Burden: Preexisting Physical and Psychiatric Comorbidities and Differential Increases Among Male and Female Participants After Initiating Antiretroviral Therapy in the HIV Outpatient Study,2008–2018
Attention to non-AIDS comorbidities is increasingly important in the HIV care and management in the United States. We sought to assess comorbidities before and after antiretroviral therapy (ART) initiation among persons with HIV (PWH). Using the 2008–2018 HIV Outpatient Study (HOPS) data, we assessed changes in prevalence of physical and psychiatric comorbidities, by sex, among participants initiating ART. Cox proportional hazards models were fit to investigate factors associated with the first documented occurrence of key comorbidities, adjusting for demographics and other covariates, including insurance type, CD4+ cell count, ART regimen, and smoking status. Among 1,236 participants who initiated ART (median age 36 years, CD4 cell count 375 cells/mm3), 79% were male, 66% non-white, 44% publicly insured, 53% ever smoked, 33% had substance use history, and 22% had body mass index ≥30 kg/m2. Among females, the percentages with at least one condition were: at ART start, 72% had a physical and 42% a psychiatric comorbidity, and after a median of 6.1 years of follow-up, these were 87% and 63%, respectively. Among males, the percentages with at least one condition were: at ART start, 61% had a physical and 32% a psychiatric comorbidity, and after a median of 4.6 years of follow-up, these were 82% and 53%, respectively. In multivariable Cox proportional hazards analyses, increasing age and higher viral loads (VL) were associated with most physical comorbidities, and being a current/former smoker and higher VL were associated with all psychiatric comorbidities analyzed. HOPS participants already had a substantial burden of physical and psychiatric comorbidities at the time of ART initiation. With advancing age, PWH who initiate ART experience a clinically significant increase in the burden of chronic non-HIV comorbidities that warrants continued surveillance, prevention, and treatment.
Get full access to this article
View all access options for this article.
References
1.
DeeksSG, LewinSR, HavlirDV: The end of AIDS: HIV infection as a chronic disease. Lancet, 2013; 382:1525–1533.
2.
LegarthRA, AhlströmMG, KronborgG, et al.: Long-term mortality in HIV-infected individuals 50 years or older: A nationwide, population-based cohort study. J Acquir Immune Defic Syndr, 2016; 71:213–218.
3.
LohseN, HansenAB, PedersenG, et al.: Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med, 2007; 146:87–95.
4.
LosinaE, SchackmanBR, SadownikSN, et al.: Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: Impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis, 2009; 49:1570–1578.
5.
SiddiqiAE, HuX, HallHI: Mortality among blacks or African Americans with HIV infection—United States, 2008–2012. MMWR Morb Mortal Wkly Rep, 2015; 64:81–86.
6.
BuchaczK, ArmonC, PalellaFJJr, et al.: The HIV Outpatient Study-25 years of HIV patient care and epidemiologic research. Open Forum Infect Dis, 2020; 7:ofaa123.
7.
AlthoffKN, JacobsonLP, CranstonRD, et al.: Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci, 2014; 69:189–198.
8.
BengtsonAM, PenceBW, PowersKA, et al.: Trajectories of depressive symptoms among a population of HIV-infected men and women in routine HIV care in the United States. AIDS Behav, 2018; 22:3176–3187.
9.
MayerKH, LooS, CrawfordPM, et al.: Excess clinical comorbidity among HIV-infected patients accessing primary care in US community health centers. Public Health Rep, 2018; 133:109–118.
10.
RaghavanA, RimmelinDE, FitchKV, ZanniMV: Sex differences in select non-communicable HIV-associated comorbidities: Exploring the role of systemic immune activation/inflammation. Curr HIV/AIDS Rep, 2017; 14:220–228.
11.
RonitA, GerstoftJ, NielsenL, et al.: Non-AIDS comorbid conditions in persons living with human immunodeficiency virus (HIV) compared with uninfected individuals 10 years before HIV diagnosis. Clin Infect Dis, 2018; 67:1291–1293.
12.
SerrãoR, PiñeroC, VelezJ, et al.: Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study. Int J Infect Dis, 2019; 79:94–100.
13.
WongC, GangeSJ, BuchaczK, et al.: First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000–2013. Clin Infect Dis, 2017; 64:459–467.
14.
WongC, GangeSJ, MooreRD, et al.: Multimorbidity among persons living with human immunodeficiency virus in the United States. Clin Infect Dis, 2018; 66:1230–1238.
15.
CollinsLF, ShethAN, MehtaCC, et al.: Incident non-AIDS comorbidity burden among women with or at risk for human immunodeficiency virus in the United States. Clin Infect Dis, 2021; 73:e2059–e2069.
16.
BrownTT, GuaraldiG: Multimorbidity and burden of disease. Interdiscip Top Gerontol Geriatr, 2017; 42:59–73.
17.
GaliB, EyawoO, HullMW, et al.: Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy. Curr Med Res Opin, 2019; 35:1955–1963.
18.
MacielRA, KlückHM, DurandM, SprinzE: Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: A cross-sectional study. Int J Infect Dis, 2018; 70:30–35.
19.
StoneL, LoobySE, ZanniMV: Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS, 2017; 12:585–593.
20.
CastilhoJL, RebeiroPF, ShepherdBE, et al.: Mood disorders and increased risk of noncommunicable disease in adults with HIV. J Acquir Immune Defic Syndr, 2020; 83:397–404.
21.
GuaraldiG, MalagoliA, MilicJ, et al.: Age of HIV acquisition affects the risk of multi-morbidity after 25 years of infection exposure. J Frailty Aging, 2019; 8:88–92.
22.
HeywoodW, LyonsA: HIV and elevated mental health problems: Diagnostic, treatment, and risk patterns for symptoms of depression, anxiety, and stress in a national community-based cohort of gay men living with HIV. AIDS Behav, 2016; 20:1632–1645.
23.
MilaniniB, CatellaS, PerkovichB, et al.: Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: The UCSF HIV over 60 cohort study. AIDS Care, 2017; 29:1178–1185.
24.
SchwartzRM, MansoorA, WilsonTE, et al.: Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women. AIDS Care, 2012; 24:394–403.
25.
IronsonG, FitchC, StuetzleR: Depression and survival in a 17-year longitudinal study of people with HIV: Moderating effects of race and education. Psychosom Med, 2017; 79:749–756.
26.
NandiA, GlymourMM, SubramanianSV: Association among socioeconomic status, health behaviors, and all-cause mortality in the United States. Epidemiology, 2014; 25:170–177.
27.
LeddyAM, RoqueA, SheiraLA, et al.: Food insecurity is associated with inflammation among women living with HIV. J Infect Dis, 2019; 219:429–436.
28.
HodesRJ, SierraF, AustadSN, et al.: Disease drivers of aging. Ann N Y Acad Sci, 2016; 1386:45–68.
29.
KarpiakSE, HavlikR: Are HIV-infected older adults aging differently?. Interdiscip Top Gerontol Geriatr, 2017; 42:11–27.
30.
ThurnM, GustafsonDR: Faces of frailty in aging with HIV infection. Curr HIV/AIDS Rep, 2017; 14:31–37.
31.
ShielsMS, AlthoffKN, PfeifferRM, et al.: HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers. Clin Infect Dis, 2017; 64:468–475.
32.
PalellaFJ, HartR, ArmonC, et al.: Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care. AIDS, 2019; 33:2327–2335.
33.
CollinsLF, ShethAN, MehtaCC, et al.: The prevalence and burden of non-AIDS comorbidities among women living with or at-risk for HIV infection in the United States. Clin Infect Dis, 2021; 72:1301–1311.
34.
WhittleHJ, SheiraLA, WolfeWR, et al.: Food insecurity is associated with anxiety, stress, and symptoms of posttraumatic stress disorder in a cohort of women with or at risk of HIV in the United States. J Nutr, 2019; 149:1393–1403.
35.
FeinsteinMJ, HsuePY, BenjaminLA, et al.: Characteristics, prevention, and management of cardiovascular disease in people living with HIV: A scientific statement from the American Heart Association. Circulation, 2019; 140:e98–e124.
36.
O'HalloranJA, SahrmannJ, ButlerAM, OlsenMA, PowderlyWG: Brief report: Integrase strand transfer inhibitors are associated with lower risk of incident cardiovascular disease in people living with HIV. J Acquir Immune Defic Syndr, 2020; 84:396–399.
37.
WaldronEM, Burnett-ZeiglerI, WeeV, et al.: Mental health in women living with HIV: The unique and unmet needs. J Int Assoc Provid AIDS Care, 2021; 20:2325958220985665.
38.
KingRM, VidrineDJ, DanyshHE, et al.: Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS, 2012; 26:479–485.
39.
NelA, KageeA: Common mental health problems and antiretroviral therapy adherence. AIDS Care, 2011; 23:1360–1365.
40.
AlthoffKN, McGinnisKA, WyattCM, et al.: Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis, 2015; 60:627–638.
41.
AlthoffKN, SmitM, ReissP, JusticeAC: HIV and ageing: Improving quantity and quality of life. Curr Opin HIV AIDS, 2016; 11:527–536.
42.
FrederickT, BurianP, TerraultN, et al.: Factors associated with prevalent hepatitis-C infection among HIV-infected women with no reported history of injection drug use: The Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS, 2009; 23:915–923.
43.
National Center for Health Statistics: Health. 2018. Available at https://www.cdc.gov/nchs/data/hus/hus18.pdf, accessed May14, 2022.
44.
StewartDW, JonesGN, MinorKS: Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med, 2011; 37:77–80.
45.
Pericot-ValverdeI, HeoM, AkiyamaMJ, et al.: Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: Secondary analysis of the PREVAIL randomized clinical trial. BMC Infect Dis, 2020; 20:928.
46.
RichterKP, AhluwaliaHK, MosierMC, et al.: A population-based study of cigarette smoking among illicit drug users in the United States. Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: Secondary analysis of the PREVAIL randomized clinical trial. Addiction, 2002; 97:861–869.
47.
WeinbergerAH, SmithPH, FunkAP, RabinS, ShuterJ: Sex differences in tobacco use among persons living with HIV/AIDS: A systematic review and meta-analysis. J Acquir Immune Defic Syndr, 2017; 74:439–453.
48.
BurkhalterJE, SpringerCM, ChhabraR, OstroffJS, RapkinBD: Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res, 2005; 7:511–522.
49.
GoldbergD, WeberKM, OrsiJ, et al.: Smoking cessation among women with and at risk for HIV: Are they quitting?. J Gen Intern Med, 2010; 25:39–44.
50.
ShirleyDK, KesariRK, GlesbyMJ: Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS, 2013; 27:604–612.
51.
ErlandsonKM, ZhangL, LakeJE, et al.: Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women. Medicine (Baltimore), 2016; 95:e5399.
52.
HalesCM, CarrollMD, FryarCD, OgdenCL: Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, 2020; 1–8.
53.
BradleyELP, FrazierEL, CarreeT, Hubbard McCreeD, SuttonMY: Psychological and social determinants of health, antiretroviral therapy (ART) adherence, and viral suppression among HIV-positive black women in care. AIDS Care, 2019; 31:932–941.
54.
LoobySE, PsarosC, RaggioG, et al.: Association between HIV status and psychological symptoms in perimenopausal women. Menopause, 2018; 25:648–656.
55.
MillsJC, PenceBW, ToddJV, et al.: Cumulative burden of depression and all-cause mortality in women living with human immunodeficiency virus. Clin Infect Dis, 2018; 67:1575–1581.
56.
PenceBW, MillsJC, BengtsonAM, et al.: Association of increased chronicity of depression with HIV appointment attendance, treatment failure, and mortality among HIV-Infected Adults in the United States. JAMA Psychiatry, 2018; 75:379–385.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
